Navigation Links
Higher Risk of Death for Babies Born Just a Few Weeks Early, Study Finds
Date:11/12/2007

WHITE PLAINS, N.Y., Nov. 13 /PRNewswire-USNewswire/ -- Babies born just a few weeks premature are six times more likely to die during their first week of life than full-term babies, according to an analysis published in the Journal of Pediatrics.

"We have known from previous studies that late preterm infants have greater risk of certain problems like respiratory distress syndrome (RDS), feeding difficulties, temperature instability (hypothermia), jaundice and brain development, Now we have evidence that there is a greater risk of death among these babies," said Dr. Jennifer L. Howse, president of the March of Dimes Foundation.

November 13 is Prematurity Awareness Day, a time for Americans to recognize the growing crisis of premature birth, and an opportunity for the March of Dimes to put forward programs to address this national problem.

Late preterm babies, those born at 34 to 36 weeks gestation (full term is birth at 37 completed weeks gestation), account for 71 percent of all premature births. The national preterm birth rate is 12.5 percent which means that more than 500,000 infants are born too soon each year.

In 2005, the nation's annual societal cost (medical, educational, and lost productivity) from preterm birth was $26.2 billion and average first year medical costs were about 10 times greater for preterm than for term infants.

But the financial costs pale in comparison to the devastating consequences shown in the study.

"This study adds to our growing knowledge of the increased medical complications and higher risk of infant death among late preterm infants compared with babies born full term," said Joann Petrini, PhD. director of the March of Dimes Perinatal Data Center and one of the study's co-authors. "Babies born even just a few weeks too soon should be closely monitored."

"Late preterm and full term infants have different risks for death in the first year of life and our study found the greatest disparity - a six-fold difference - in the first week of life," said Kay M. Tomashek, MD, MPH, a researcher at the U.S. Centers for Disease Control and Prevention and the paper's lead author.

Differences in Mortality Between Late-Preterm and Term Singleton Infants in the United States, 1995-2002, is being published in the November 2007 Journal of Pediatrics, Vol. 151, No. 5.

Today, the March of Dimes concluded its month-long "Every Baby Has a Story" tour with a final stop at Times Square in New York City. The tour helped raise awareness nationwide by visiting 16 cities and collecting thousands of baby stories - of babies born healthy as well as those who need help to survive and thrive. People can add stories at http://www.marchofdimes.com/everybaby.

The March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For more information, visit marchofdimes.com or nacersano.org for Spanish.


'/>"/>
SOURCE March of Dimes
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Hushed Genes Might Mean Higher Lung Cancer Risk
4. Higher death rates in kidney patients with newly recognized disease
5. Vulnerable groups are not at higher risk of physician-assisted death
6. Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms
7. In birds, expecting to mate leads to higher fertilization rates
8. COPD rates, higher than expected in China, will continue to grow
9. Caesarean births pose higher risks for mother and baby
10. CDC Reports Prevalence of Worms Transmitted by Dogs and Cats to Humans is Higher Than Previously Understood
11. Diesel exhaust associated with higher heart attack, stroke risk in men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... January 19, 2017 , ... Connecticut Dermatology Group (CDG) ... a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background in ... “It is with considerable pleasure to welcome back Dr. Kim to the CDG team” ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... From a ... are released almost daily linking gut health to chronic disease, mental health and general ... Year ” as an important resolution to consider. , For one Charlottesville restaurant, good ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm®, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: